BACKGROUND: The assessment of Quality of Life (QoL) is an important tool for elucidating target symptoms that are particularly bothersome to patients. The present study was designed to explore predictors of decreased QoL in obsessive-compulsive disorder (OCD) patients and to explore which aspects of QoL are most affected in OCD. Furthermore, the study investigated changes in QoL after treatment and the association between QoL change scores with symptomatic outcome. In line with prior research, it was expected that low QoL in OCD patients would be most pronounced for the emotional and social aspects of the construct. METHODS: Seventy-nine OCD patients were initially recruited. Patients were assessed with the SF-36 both before and after treatment. Norm values were derived from the general population to characterize status of impairment. OCD patients were contrasted with published SF-36 scores from 2 OCD samples as well as a newly recruited psychiatric and healthy control sample. RESULTS: Correlations with QoL were most pronounced for depression severity and number of OCD symptoms. Apart from low social and emotional QoL in the majority of patients, a large subgroup also reported lower physical well-being. Decreased scores on this subscale were mainly associated with length of illness, depression, and number of compulsions. Overall, QoL was significantly improved in therapy responders relative to nonresponders. CONCLUSIONS: The results largely correspond to previous findings showing that OCD patients share severely compromised well-being. Somewhat unexpected from previous research, QoL deficits were not restricted to emotional and social aspects of QoL but extended to somatic domains. The present results suggest that clinicians should thoroughly explore for depression as well as physical impairments in OCD patients, which, when present, may be additionally targeted to achieve comprehensive treatment success.
BACKGROUND: The assessment of Quality of Life (QoL) is an important tool for elucidating target symptoms that are particularly bothersome to patients. The present study was designed to explore predictors of decreased QoL in obsessive-compulsive disorder (OCD) patients and to explore which aspects of QoL are most affected in OCD. Furthermore, the study investigated changes in QoL after treatment and the association between QoL change scores with symptomatic outcome. In line with prior research, it was expected that low QoL in OCDpatients would be most pronounced for the emotional and social aspects of the construct. METHODS: Seventy-nine OCDpatients were initially recruited. Patients were assessed with the SF-36 both before and after treatment. Norm values were derived from the general population to characterize status of impairment. OCDpatients were contrasted with published SF-36 scores from 2 OCD samples as well as a newly recruited psychiatric and healthy control sample. RESULTS: Correlations with QoL were most pronounced for depression severity and number of OCD symptoms. Apart from low social and emotional QoL in the majority of patients, a large subgroup also reported lower physical well-being. Decreased scores on this subscale were mainly associated with length of illness, depression, and number of compulsions. Overall, QoL was significantly improved in therapy responders relative to nonresponders. CONCLUSIONS: The results largely correspond to previous findings showing that OCDpatients share severely compromised well-being. Somewhat unexpected from previous research, QoL deficits were not restricted to emotional and social aspects of QoL but extended to somatic domains. The present results suggest that clinicians should thoroughly explore for depression as well as physical impairments in OCDpatients, which, when present, may be additionally targeted to achieve comprehensive treatment success.
Authors: Katarina Stengler-Wenzke; Michael Kroll; Herbert Matschinger; Matthias C Angermeyer Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2006-05-23 Impact factor: 4.328
Authors: Jonathan D Huppert; H Blair Simpson; Kore J Nissenson; Michael R Liebowitz; Edna B Foa Journal: Depress Anxiety Date: 2009 Impact factor: 6.505
Authors: Eric A Storch; Brent J Small; Joseph F McGuire; Tanya K Murphy; Sabine Wilhelm; Daniel A Geller Journal: J Child Adolesc Psychopharmacol Date: 2017-09-14 Impact factor: 2.576
Authors: Anne Katrin Külz; Sarah Landmann; Barbara Cludius; Birgit Hottenrott; Nina Rose; Thomas Heidenreich; Elisabeth Hertenstein; Ulrich Voderholzer; Steffen Moritz Journal: BMC Psychiatry Date: 2014-11-18 Impact factor: 3.630
Authors: Anne Katrin Külz; Sarah Landmann; Barbara Cludius; Nina Rose; Thomas Heidenreich; Lena Jelinek; Heike Alsleben; Karina Wahl; Alexandra Philipsen; Ulrich Voderholzer; Jonathan G Maier; Steffen Moritz Journal: Eur Arch Psychiatry Clin Neurosci Date: 2018-11-16 Impact factor: 5.270
Authors: L A Brown; J L Krull; P Roy-Byrne; C D Sherbourne; M B Stein; G Sullivan; R D Rose; A Bystritsky; M G Craske Journal: Psychol Med Date: 2014-10-02 Impact factor: 7.723
Authors: Monnica T Williams; Robert Joseph Taylor; Joseph A Himle; Linda M Chatters Journal: J Obsessive Compuls Relat Disord Date: 2017-07-08 Impact factor: 1.677